Skip to main content

Table 5 In vitro drug release study of the 9 batches of microspheres

From: Pharmacoscintigraphic evaluation and antidiabetic efficacy of gliclazide-loaded 99mTc-labelled mucoadhesive microspheres

  F1 F2 F3 F4 F5 F6 F7 F8 F9
0 0 0 0 0 0 0 0 0 0
1 10.47 16.21 13.25 14.21 15.87 17.42 14.55 12.28 13.23
2 13.92 21.42 16.67 19.5 18.27 25.93 21.53 21.34 19.45
3 19.63 25.32 21.36 24.63 27.9 35.59 29.53 28.8 27.66
4 24.2 31.82 24.68 32.8 32.62 47.46 39.34 39.54 38.48
5 28.14 37.21 28.18 38.73 38.85 56.58 44.5 46.45 49.9
6 35.81 43.81 34.41 43.21 43.17 60.22 52.26 54.32 55.65
7 42.16 48.21 41.37 49.98 51.39 67.64 59.36 60.86 63.32
8 48.33 54.31 47.54 54.72 60.42 75.27 64.66 68.88 69.19
9 54.42 61.88 54.83 61.24 68.25 82.19 71.48 72.1 73.54
10 59.56 67.21 62.74 66.65 74.76 87.33 83.4 75.58 76.55
11 66.25 71.58 69.14 72.37 80.56 91.43 85.5 80.45 78.58
12 75.4 78.87 76.87 81.1 86.25 97.44 90.55 88.66 81.2
  1. *Values are indicated as percent (%) cumulative drug release